
معرفی
Mark Oremus is a Professor at the University of Waterloo, specializing in Epidemiology and Biostatistics. He holds affiliations as a health and aging researcher and a health neuroscience and cognitive epidemiology researcher. His work focuses on aging populations, chronic disease, cognition, and dementia, particularly Alzheimer’s disease. He has conducted studies on health policy, economics, and knowledge transfer, emphasizing systematic reviews and mixed-methods approaches.
Education: Oremus earned a BA in Political Science from McGill University, an MA in Public Policy and Administration from Concordia University, and both an MSc and PhD in Epidemiology and Biostatistics from McGill University. His academic journey bridges public policy, political science, and quantitative health sciences.
Research Interests: Oremus’s primary research explores social determinants of health in aging populations, including social isolation, loneliness, religiosity, and their impacts on cognitive function and memory. He investigates interventions for frailty screening, telehealth for chronic disease management, and the efficacy of assistive devices for older adults. His work also addresses disparities in healthcare access and outcomes, particularly in marginalized communities.
Publications: His articles analyze relationships between social factors and cognitive health, evaluate healthcare interventions, and assess methodological rigor in mixed-methods research. Notable themes include longitudinal studies of aging cohorts (e.g., Canadian Longitudinal Study on Aging) and systematic reviews on topics like religiosity and cancer screening.
Awards: No scientific awards are explicitly listed in the provided texts.
Advising & Grants: Oremus is currently not accepting graduate students, though past work indicates supervision of interdisciplinary research. His grants likely support large-scale population studies and methodological reviews, though specific grant details are not disclosed here.
Labs/Teams: Affiliations imply collaboration with aging-focused research groups, public health policy teams, and interdisciplinary initiatives in cognitive epidemiology, though specific lab names are not mentioned.